L.V.G. PHARMA
0861.341.984 · rovalta.com · 24/09/2026
ACTIVE
L.V.G. PHARMA
Financial year 2025 · Closed on 31/12/2025
Net result
99,1 k €
+9,2 %over 1 yearGross margin
122,3 k €
-0,5 %over 1 yearEquity
799,3 k €
+14,1 %over 1 yearOverview
Identity
Source · BCE/KBOL.V.G. PHARMA is a Private limited company incorporated in 2003. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Puurs-Sint-Amands.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0861.341.984
- Incorporation
- 29/10/2003
- Legal form
- Private limited company
- Registered office
- Kleine Amer 49
2870 Puurs-Sint-Amands · FlandreSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2025
Activities (NACE)
Joint committees (1)
- 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 20 filingsTrend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 122,3 k € | -0.5% | 122,9 k € | +1.0% | 121,7 k € | -2.5% | 124,8 k € | +3.2% | 121 k € |
| EBITDA | 121,9 k € | -0.5% | 122,6 k € | +1.2% | 121,2 k € | -2.7% | 124,5 k € | +3.1% | 120,7 k € |
| Operating result | 121,3 k € | -0.4% | 121,9 k € | +1.2% | 120,5 k € | -2.9% | 124,2 k € | +3.1% | 120,5 k € |
| Net result | 99,1 k € | +9.2% | 90,8 k € | -0.0% | 90,8 k € | -1.5% | 92,2 k € | +17.5% | 78,4 k € |
| Balance sheet | |||||||||
| Equity | 799,3 k € | +14.1% | 700,9 k € | -2.1% | 715,7 k € | -2.0% | 730,6 k € | +4.9% | 696,3 k € |
| Total assets | 1,1 M € | -0.8% | 1,1 M € | -1.2% | 1,1 M € | +2.9% | 1 M € | +3.5% | 1 M € |
| Cash | 57,2 k € | -50.1% | 114,5 k € | -10.2% | 127,6 k € | -35.0% | 196,3 k € | +21.2% | 162 k € |
| Debts | 248,9 k € | -29.5% | 353,2 k € | +0.2% | 352,6 k € | +15.3% | 305,8 k € | +0.3% | 305 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20251 active · 6 ended
Active mandates
Godelieve Van Achter
ActiveEnded mandates
Godelieve Van Achter
EndedGodelieve Van Achter
EndedGodelieve Vanachter
EndedLieve Van Achter
EndedFinancials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 27/05/2026 | 18/07/2025 | 10/06/2024 | 09/06/2023 | 30/05/2022 | 08/06/2021 |
| General meeting | 08/05/2026 | 09/05/2025 | 10/05/2024 | 12/05/2023 | 13/05/2022 | 14/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 08/05/2026 | 27/05/2026 | Dutch | |
| Abridged model | 31/12/2024 | 09/05/2025 | 18/07/2025 | Dutch | |
| Micro model | 31/12/2023 | 10/05/2024 | 10/06/2024 | Dutch | |
| Micro model | 31/12/2022 | 12/05/2023 | 09/06/2023 | Dutch | |
| Micro model | 31/12/2021 | 13/05/2022 | 30/05/2022 | Dutch | |
| Micro model | 31/12/2020 | 14/05/2021 | 08/06/2021 | Dutch | |
| Micro model | 31/12/2019 | 08/05/2020 | 15/05/2020 | Dutch | |
| Micro model | 31/12/2018 | 10/05/2019 | 07/06/2019 | Dutch | |
| Micro model | 31/12/2017 | 11/05/2018 | 04/06/2018 | Dutch | |
| Abridged model | 31/12/2016 | 12/05/2017 | 18/05/2017 | Dutch | |
| Abridged model | 31/12/2015 | 13/05/2016 | 08/06/2016 | Dutch | |
| Abridged model | 31/12/2014 | 08/05/2015 | 21/05/2015 | Dutch | |
| Abridged model | 31/12/2013 | 09/05/2014 | 21/05/2014 | Dutch | |
| Abridged model | 31/12/2012 | 10/05/2013 | 30/05/2013 | Dutch | |
| Abridged model | 31/12/2011 | 11/05/2012 | 18/05/2012 | Dutch | |
| Abridged model | 31/12/2010 | 13/05/2011 | 31/05/2011 | Dutch | |
| Abridged model | 31/12/2009 | 14/05/2010 | 14/06/2010 | Dutch | |
| Abridged model | 31/12/2008 | 08/05/2009 | 04/06/2009 | Dutch | |
| Abridged model | 31/12/2007 | 30/05/2008 | 19/06/2008 | Dutch | |
| Abridged model | 31/12/2006 | 01/06/2007 | 21/06/2007 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 6 ended
Active mandates
Godelieve Van Achter
ActiveEnded mandates
Godelieve Van Achter
EndedGodelieve Van Achter
EndedGodelieve Vanachter
EndedLieve Van Achter
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates13/10/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
- Capital / shares02/05/2018KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Capital / shares04/02/2014KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Other05/11/2003RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202599,1 k €↑
- 2024Annual accounts 202490,8 k €↓
- 2023Annual accounts 202390,8 k €↓
- 2022Annual accounts 202292,2 k €↑
- 2021Annual accounts 202178,4 k €↓
- 2020Annual accounts 202085,2 k €↓
- 2019Annual accounts 201993,7 k €↓
- 2018Annual accounts 2018252,3 k €↑
- 2017Annual accounts 201757,2 k €↓
- 2016Annual accounts 201660,5 k €↑
- 2015Annual accounts 201559,9 k €↑
- 2014Annual accounts 201456,4 k €↓
- 2013Annual accounts 2013104,9 k €↑
- 2012Annual accounts 201260,7 k €↑
- 2011Annual accounts 201152,9 k €↓
- 2010Annual accounts 201062,2 k €↓
- 2009Annual accounts 200963,8 k €↓
- 2008Annual accounts 2008145,6 k €↑
- 2007Annual accounts 200746,6 k €↑
- 2006Annual accounts 200645,4 k €
- 29/10/2003IncorporationPrivate limited company